DLST Human

Dihydrolipoamide S-Succinyltransferase Human Recombinant
Cat. No.
BT3644
Source
Sf9 insect cells.
Synonyms
dihydrolipoamide S-succinyltransferase (E2 component of 2-oxo-glutarate complex), Dihydrolipoamide succinyltransferase component of 2-oxoglutarate dehydrogenase complex, component E2, DLST, E2K, OGDC-E2, EC 2.3.1.61, EC 2.3.1.
Appearance
Purity
DLST purity was found to be greater than 75% as determined by SDS-PAGE.
Usage
Prospec's products are furnished for LABORATORY RESEARCH USE ONLY. The product may not be used as drugs, agricultural or pesticidal products, food additives or household chemicals.
Shipped with Ice Packs
In Stock

Description

DLST is a Full-length cDNA coding for the mature form of the human OGDC-E2 protein having a molecular mass of 42,301 Dalton (pH 6.3).DLST protein is fused to a hexa-histidine purification tag.

Product Specs

Introduction
The enzyme DLST facilitates the conversion of 2-oxoglutarate into succinyl-CoA and CO2. This enzyme is comprised of multiple copies of three enzymatic components: 2-oxoglutarate dehydrogenase (E1), dihydrolipoamide succinyltransferase (E2), and lipoamide dehydrogenase (E3).
Description
DLST is a full-length cDNA that codes for the mature human OGDC-E2 protein. This protein has a molecular mass of 42,301 Daltons at a pH of 6.3 and is fused to a hexa-histidine purification tag.
Formulation
DLST is provided at a concentration of 0.74 mg/ml in a buffer solution containing 20mM HEPES (pH 8.0), 200mM NaCl, and 20% glycerol.
Immunological Functions
DLST can bind to IgG-type human auto-antibodies and is suitable for use in standard ELISA tests (including checkerboard analysis of positive and negative sera panels) and immunodot tests with positive and negative sera panels.
Applications
DLST is suitable for use in Western blot analysis with anti-M2-Antigen autoantibody-positive patient sera or monoclonal anti-hexa-His-tag antibodies.
Coating Concentration
The recommended coating concentration for DLST is 0.4-1.0 µg/ml, depending on the ELISA plate type and coating buffer. DLST is suitable for biotinylation and iodination.
Stability
For short-term storage (2-4 weeks), DLST can be stored at 4°C. For long-term storage, DLST should be stored frozen at -20°C. Avoid repeated freeze-thaw cycles.
Purity
SDS-PAGE analysis has determined that the purity of DLST is greater than 75%.
Synonyms
dihydrolipoamide S-succinyltransferase (E2 component of 2-oxo-glutarate complex), Dihydrolipoamide succinyltransferase component of 2-oxoglutarate dehydrogenase complex, component E2, DLST, E2K, OGDC-E2, EC 2.3.1.61, EC 2.3.1.
Source
Sf9 insect cells.

Product Science Overview

Introduction

Dihydrolipoamide S-Succinyltransferase, also known as DLST, is a crucial enzyme in the human body. It is a component of the 2-oxoglutarate dehydrogenase complex, which plays a significant role in the citric acid cycle (also known as the Krebs cycle or TCA cycle). This enzyme is essential for cellular respiration, a process that generates energy in the form of adenosine triphosphate (ATP) by oxidizing acetyl-CoA derived from carbohydrates, fats, and proteins.

Structure and Function

Dihydrolipoamide S-Succinyltransferase is a mitochondrial protein that belongs to the 2-oxoacid dehydrogenase family. It is one of the three core components of the 2-oxoglutarate dehydrogenase complex, along with the E1 (2-oxoglutarate dehydrogenase) and E3 (dihydrolipoamide dehydrogenase) components . The primary function of DLST is to catalyze the transfer of a succinyl group from succinyl-CoA to dihydrolipoamide, forming succinyl-dihydrolipoamide and releasing CoA-SH .

Genetic Information

The DLST gene is located on chromosome 14 in humans and encodes the dihydrolipoamide S-succinyltransferase protein . This gene is highly conserved across different species, indicating its essential role in cellular metabolism. Alternative splicing of the DLST gene results in multiple transcript variants, which may lead to different isoforms of the protein .

Clinical Significance

Mutations in the DLST gene have been associated with various metabolic disorders. For instance, defects in the DLST gene can lead to Pheochromocytoma/Paraganglioma Syndrome 7 and Hereditary Paraganglioma-Pheochromocytoma Syndromes . These conditions are characterized by the development of tumors in the adrenal glands and other parts of the body. Additionally, the enzyme’s role in the citric acid cycle makes it a potential target for therapeutic interventions in metabolic diseases and cancer .

Recombinant DLST

Recombinant DLST refers to the enzyme produced through recombinant DNA technology, which involves inserting the DLST gene into a suitable expression system, such as bacteria or yeast, to produce the protein in large quantities. This recombinant protein is used in various research applications, including studying the enzyme’s structure and function, investigating its role in metabolic pathways, and developing potential therapeutic agents.

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2024 Thebiotek. All Rights Reserved.